Nothing in this Directive shall permit the marketing of a proprietary medicinal product in respect of which the authorization provided for in Article 3 of Directive 65/65/EEC has not been issued.
Article 3 Without prejudice to Article 4, the following provisions shall apply if an increase in the price of a medicinal product is permitted only after prior approval has been obtained from the competent authorities: 1.
Member States shall ensure that a reasoned decision on any such application is adopted and communicated to the applicant within 90 days.
They shall forthwith inform the Commission thereof. 2.
